Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD
Trial details
- Registry ID
- NCT05711940
- Drugs studied
- Psilocybin
TrialRedline tracks 7 clinical trials sponsored by COMPASS Pathways: 2 Phase 3, 1 Phase 2 / 3, 4 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRDNCT05711940 | Psilocybin | Active not recruiting | 2025-11-13Actual |
| Efficacy, Safety, and Tolerability of COMP360 in Participants With TRDNCT05624268 | Psilocybin | Completed | 2025-05-28Actual |
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress DisorderNCT07570654 | COMP360 psilocybin | Recruiting | 2028-11Estimated |
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive DisorderNCT05733546 | Psilocybin | Active not recruiting | 2025-09Estimated |
| Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept StudyNCT05481736 | Psilocybin | Completed | 2024-11-18Actual |
| The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress DisorderNCT05312151 | Psilocybin | Completed | 2024-02-12Actual |
| The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant DepressionNCT04739865 | Psilocybin | Completed | 2021-10-14Actual |
Names as written in the registry records.
Before: Not yet recruiting. After: Recruiting.
NCT05624268 · COMPASS Pathways
Before: Estimated. After: Actual.
Before: 255 participants (planned). After: 258 participants (actual).
Before: Active not recruiting. After: Completed.
NCT05711940 · COMPASS Pathways
Before: Estimated. After: Actual.
Before: Feb 2026. After: 13 Nov 2025.